Literature DB >> 2331470

High-density-lipoprotein-induced cholesterol efflux from arterial smooth muscle cell derived foam cells: functional relationship of the cholesteryl ester cycle and eicosanoid biosynthesis.

K B Pomerantz1, D P Hajjar.   

Abstract

Eicosanoids have been implicated in the regulation of arterial smooth muscle cell (SMC) cholesteryl ester (CE) metabolism. These eicosanoids, which include prostacyclin (PGI2), stimulate CE hydrolytic activities. High-density lipoproteins (HDL), which promote cholesterol efflux, also stimulate PGI2 production, suggesting that HDL-induced cholesterol efflux is modulated by eicosanoid biosynthesis. To ascertain the role of endogenously synthesized eicosanoids produced by arterial smooth muscle cells in the regulation of CE metabolism, we examined the effects of cyclooxygenase inhibition on CE hydrolytic enzyme activities, cholesterol efflux, and cholesterol content in normal SMC and SMC-derived foam cells following exposure to HDL and another cholesterol acceptor protein, serum albumin. Alterations of these activities were correlated with cholesterol efflux in response to HDL or bovine serum albumin (BSA) in the presence or absence of aspirin. HDL stimulated PGI2 synthesis and CE hydrolases in a dose-dependent manner. Eicosanoid dependency was established by demonstrating that HDL-induced acid cholesteryl ester hydrolase (ACEH) activity was blocked by aspirin. CE enrichment essentially abrogated HDL-induced PGI2 production in cells which also exhibited decreased lysosomal and cytoplasmic CE hydrolase activities. In CE-enriched cells whose cytoplasmic CE pool was metabolically labeled with [3H]oleate or cLDL containing [3H]cholesteryl linoleate, aspirin did not alter HDL- or BSA-induced net CE hydrolysis or efflux, respectively. Finally, aspirin treatment did not alter the mass of either free or esterified cholesterol content of untreated or CE-enriched SMC following exposure to acceptor proteins. These data demonstrated that CE enrichment significantly reduced HDL-induced activation of CE hydrolytic activity via inhibition of endogenous PGI2 production.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331470     DOI: 10.1021/bi00459a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.

Authors:  Y Nagano; H Arai; T Kita
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts.

Authors:  J Belkner; H Stender; H G Holzhütter; C Holm; H Kühn
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

3.  Analysis of the physical state of cholesteryl esters in arterial-smooth-muscle-derived foam cells by differential scanning calorimetry.

Authors:  D P Hajjar; K B Pomerantz; J W Snow
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

4.  Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages.

Authors:  T Inaba; H Shimano; T Gotoda; K Harada; M Shimada; M Kawamura; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Overexpression of human 15(S)-lipoxygenase-1 in RAW macrophages leads to increased cholesterol mobilization and reverse cholesterol transport.

Authors:  Ginny L Weibel; Michelle R Joshi; Eric T Alexander; Peijuan Zhu; Ian A Blair; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

6.  Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.

Authors:  Devashish Kothapalli; Ilia Fuki; Kamilah Ali; Sheryl A Stewart; Liang Zhao; Ron Yahil; David Kwiatkowski; Elizabeth A Hawthorne; Garret A FitzGerald; Michael C Phillips; Sissel Lund-Katz; Ellen Puré; Daniel J Rader; Richard K Assoian
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.